Seeking Alpha
 

Rock Creek Pharmaceuticals, Inc. (RCPI)

- NASDAQ
  • Jan. 16, 2014, 9:10 AM
    | 1 Comment
  • Jan. 2, 2014, 12:45 PM
    | 2 Comments
  • Dec. 31, 2013, 10:33 AM
    • Star Scientific (STSI -6%) acknowledges it received a warning letter on Dec. 20 from the FDA stating "[Y]our Anatabloc and CigRx products contain anatabine [...] Anatabine [...] is also considered a new dietary ingredient, which is subject to premarket approval. To date, a premarket notification has not submitted to FDA; [...] therefore, [Anatabloc and CigRx] are deemed to be adulterated."
    • The agency continues that Anatabloc has been advertised by Star Scientific on its websites as a drug, which the FDA has "not generally recognized as safe and effective for the [...] referenced uses."  The FDA urges Star Scientific to "take prompt action to correct the violations." Failure "may result in regulatory action without further notice, such as seizure and/or injunction."
    • Star Scientific is "responding to the letter and has already advised the agency that it intends to work cooperatively to resolve these issues, including undertaking a review of the Company's websites."
    | 4 Comments
  • Oct. 14, 2013, 2:57 PM
    • The situation at Star Scientific (STSI +0.9%) is bleak, according to SA contributor Paulo Santos.
    • He thinks the company's desperate measure to raise capital through the issuance of new shares is just buying time with hopes for a revenue bonanza fading.
    • The bull case on STSI hinges on the potential for Anatabloc to be a mass market product. The company expects a patent related to the treatment's active ingredient to be granted shortly.
    | 1 Comment
  • Oct. 14, 2013, 12:45 PM
    | 2 Comments
  • May. 28, 2013, 10:16 AM
    Shares of Star Scientific (STSI +11.9%) rip a double-digit gain as M&A chatter picks up again. The dietary supplement maker has been beaten down this year with a few controversies, but shares are poking their head above $1.60 for the first time in over a month.
    | Comment!
  • May. 28, 2013, 9:14 AM
    Premarket gainers: CSIQ +25%. PIP +21%. ROYL +17%. BGMD +11%. BLDP +11%. VRX +11%. SIGA +8%. TSL +8%. MAKO +8%. YGE +8%. CPST +8%. STSI +8%. HSOL +7%. ALU +7%. LDK +7%. JASO +7%. TIF +6%.
    | Comment!
  • Mar. 27, 2013, 12:54 PM
    Midday top 10 gainers: CHCI +45%. RVLT +35%. UEPS +24%. LIVE +20%. UTSI +20%. ECYT +11%. MFRM +10%. STSI +10%. PGTI +10%. GSL +10%.
    Midday top 10 losers: ASTM -38%. EVBS -23%. ISNS -19%. ATOS -14%. CLF -15%. BAA -13%. GV -12%. LOGM -11%. MBLX -11%. LEDS -10%.
    | Comment!
  • Mar. 27, 2013, 9:47 AM
    Star Scientific (STSI) jumps 10.1% after apparently convincing investors with its response yesterday to a class action lawsuit that questions the validity of the company's research into its dietary supplements and cosmetic products. "It is difficult to conceive of a more inappropriate class action plaintiff representative," Star said. (PR)
    | 2 Comments
  • Mar. 27, 2013, 9:25 AM
    Premarket gainers: CHCI +51%. UTSI +23%. STSI +14%. VELT +12%. CHTP +11%.  
    Losers: ASTM -37%. CLF -14%. GV -7%. LNDC -6%
    | Comment!
  • Mar. 26, 2013, 12:54 PM
    Midday top 10 gainers: PTEK +30%. BVX +23%. OPXA +20%. LEDS +20%. IBCP +13%. DXYN +11%. GTAT +11%. APP +11%. HGSH +9%. PGNX +9%.
    Midday top 10 losers: ZIOP -62%. FUQI -17%. GMAN -16%. PGTI -14%. STSI -13%. GMXR -11%. STXS -11%. PRTS -10%. REED -10%. CSUN -8%.
    | Comment!
  • Mar. 19, 2013, 1:00 PM
    Midday top 10 gainers: EFUT +53%. ATOS +29%. GST +20%. KYTH +14%. DWCH +10%. NPSP +9%. SHIP +9%. CSTE +8%. OPXA +8%. LTRX +8%.
    Midday top 10 losers: AFFY -64%. MTSL -33%. HNR -33%. WSCI -23%. WAC -19%. INTX -19%. STSI -17%. TWER -14%. CLWT -13%. GMXR -13%.
    | Comment!
  • Mar. 19, 2013, 9:39 AM
    Shares of Star Scientific (STSI -8.6%) crumble with a new SEC filing out from the company revealing it received subpoenas from the U.S. Attorney's Office in Eastern Virginia. (10-K)
    | 4 Comments
  • Mar. 19, 2013, 9:10 AM
    Premarket gainers: NPSP +10%. SKUL +7%. ABC +6%. ACAD +5%.
    Losers: AFFY -59%. HNR -46%. MTSL -30%. STSI -11%. CAH -8%. DSW -7%. HPT -6%.
    | Comment!
  • Mar. 13, 2013, 5:38 PM
    After-hours top gainers, as of 5:15 p.m.: STSI +3%. CBK +3%. ARCO +2%. ARUN +2%. BFAM +2%.
    After-hours top losers: ANAD -10%. VRA -8%. ICON -4%. ETFC -4%. SSNC -4%.
    | Comment!
  • Jan. 28, 2013, 11:56 AM
    Star Scientific (STSI -4.8%) refutes a story published last week on TheStreet.com in which accusations are leveled at the firm that it misled investors over the involvement of Johns Hopkins University with research on the nutritional supplement anatabine. "The (anatabine) study was not sponsored by the Johns Hopkins School of Medicine, and the company never reported otherwise."
    | 18 Comments
Visit Seeking Alpha's
RCPI vs. ETF Alternatives
Company Description
Rock Creek Pharmaceuticals Inc is engaged in research, development, and commercialization of compounds and formulations targeting inflammatory and neurological disorders.
Industry: Cigarettes
Country: United States